SWX/PPGNE (SWX/PPGNE)

SIX Swiss Exchange: SWX/PPGNE · CHF

CHF 44.0

-0.15 (-0.3%)· Recorded snapshot

Market cap	1.4B
Revenue (ttm)	423.6M
Net income (ttm)	13.3M
EPS (ttm)	CHF 0.41
P/E (trailing)	107.5x
P/E (forward)	43.3x
Volume	1,032

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 423.6M
Net income (ttm): 13.3M
EPS (ttm): CHF 0.41
P/E (trailing): 107.5x
P/E (forward): 43.3x
Market cap: 1.4B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-11-03 14:30 UTC

Forward P/E43.3

P25 n/aP50 n/aP75 n/a

Trailing P/E107.5

P25 n/aP50 n/aP75 n/a

ROE4.2

P25 n/aP50 n/aP75 n/a

ROIC5.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SWX/PPGNE indicators

Market & fundamental data

Available fields

182

Groups with data

Currency

EUR

Showing 182 of 182 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CHF
Country	Switzerland
Country code	CH
Earnings date	2027-03-09
Employees	1,460
Employees change	20
Employees growth	1.39%
Enterprise value	CHF 1.4B
Exchange	SIX Swiss Exchange
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-10-12
Fiscal year end	December
Founded	1952
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
ISIN number	CH1593449767
Last refreshed	2026-11-03
Market cap	CHF 1.4B
Next earnings date	2027-03-09
Price	CHF 43.95
Price currency	CHF
Sector	Healthcare
SIC code	8731
Stock price date	2026-11-02
Symbol	swx/PPGNE
Website	https://www.polypeptide.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	0.93%
EV/Earnings	108.58x
EV/EBIT	35.52x
EV/EBITDA	19.54x
EV/Sales	3.42x
FCF / EV yield	-3.17%
FCF yield	-3.36%
Forward P/E	43.29x
Graham number	10.04232
Graham upside	-77.15%
Industry P/E	60.68x
Lynch fair value	CHF 2.15
Lynch upside	-95.11%
P/(OCF - SBC) ratio	29.57x
P/B ratio	4.21x
P/E ratio	107.48x
P/OCF ratio	27.87x
P/S ratio	3.22x
Price / tangible book value	4.29x
Price/EBITDA ratio	19.6x
Sector forward P/E	19.83x
Sector P/E	34.14x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	9.63%
EBITDA margin	16.44%
Effective tax rate	42.56%
Gross margin	22.86%
Operating margin	9.63%
Pretax margin	5.48%
Profit margin	3.15%
Profit per employee	CHF 9,137
Profitable quarters	2
Revenue per employee	CHF 290,122
ROA	3.38%
ROA (5Y)	1.37%
ROCE	6.81%
ROE	4.24%
ROE (5Y)	-1.31%
ROIC	5.75%
ROIC (5Y)	3.22%
SBC / revenue	0.67%
Tax / revenue	2.33%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (QoQ)	71.11%
EPS growth 5Y	-22.35%
EPS growth quarters	2
EPS growth years	0
Gross profit growth	152.7%
Gross profit growth (Q)	287.39%
Gross profit growth 3Y	103.56%
Gross profit growth 5Y	1.5%
Net income growth (QoQ)	69.11%
Net income growth 5Y	-21.39%
Net income growth quarters	2
Net income growth years	0
OCF growth	-61.7%
OCF growth (Q)	-49.21%
OCF growth (QoQ)	-9.46%
OCF growth 5Y	-7.07%
Operating income growth 5Y	-8.97%
Revenue growth	24.4%
Revenue growth (Q)	41.61%
Revenue growth (QoQ)	6.48%
Revenue growth 3Y	18.02%
Revenue growth 5Y	11.11%
Revenue growth quarters	6
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CHF -94.9M
Depreciation and amortization	CHF 28.7M
EBIT	CHF 40.8M
EBITDA	CHF 69.7M
EPS	CHF 0.41
Financing cash flow	CHF 31.2M
Free cash flow	CHF -45.9M
Free cash flow minus SBC	CHF -48.7M
Gross profit	CHF 96.8M
Income taxes	CHF 9.9M
Investing cash flow	CHF -98.5M
Net borrowing	CHF 31M
Net cash flow	CHF -16.3M
Net income	CHF 13.3M
Operating cash flow minus SBC	CHF 46.2M
Operating income	CHF 40.8M
Revenue	CHF 423.6M
Stock-based compensation	CHF 2.8M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.29
Book value per share	CHF 9.82
Debt / EBITDA	1.86
Debt / equity	0.42
Interest coverage	4.16
Long-term assets	CHF 475.3M
Long-term liabilities	CHF 275.9M
Net cash (debt)	CHF -83.2M
Net cash / market cap	-6.1%
Net debt / EBITDA	1.2
Net debt / equity	0.26
Piotroski F-Score	7
Property, plant and equipment	CHF 440M
Shareholders' equity	CHF 324.2M
Tangible book value	CHF 318.2M
Tangible book value per share	CHF 9.64
Total assets	CHF 794.6M
Total cash	CHF 54.5M
Total debt	CHF 137.7M
Total liabilities	CHF 470.4M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.56
Current assets	CHF 319.3M
Current liabilities	CHF 194.4M
Current ratio	1.64
Inventory turnover	2.2
Net working capital	CHF 95.7M
Quick ratio	0.76
Working capital	CHF 125.8M
Working capital turnover	3.27

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.93%
Shareholder yield	1.93%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	-0.34%
1M price change	0.23%
1M total return	0.23%
1W price change	0.46%
1W total return	0.46%
20-day SMA	CHF 44.00
52-week high	CHF 44.15
52-week high date	2026-10-16
52-week low	CHF 41.00
52-week low date	2026-11-02
All-time high	CHF 44.15
All-time high date	2026-10-12
All-time low	CHF 41.00
All-time low date	2026-11-02
Average true range (ATR)	CHF 0.36
Average volume	12.4K
Change from 52-week high	-0.45%
Change from 52-week low	7.2%
Change from all-time high	-0.11%
Change from all-time low	7.56%
Change from open	7.2%
Day's gap	-7.03%
Dollar volume	CHF 45,356
High price	CHF 44.00
Low price	CHF 41.00
Monthly RSI	0
Open price	CHF 41.00
Position in 52-week range	98.33%
Previous close	CHF 44.10
Price vs 20-day SMA	0.23%
Relative volume	0.08
RSI	48.48
Sharpe ratio	-1.68
Sortino ratio	-0.38
Volume	1K
Weekly RSI	0

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	14.1M
Shares change (QoQ)	-1.37%
Shares change (YoY)	-1.93%
Shares held by insiders	1.11%
Shares held by institutions	10.35%

Deeper analysis on SWX/PPGNE

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SWX/PPGNE report

Is a complete SWX/PPGNE research report available?

No complete published report is available for swx/PPGNE (SWX/PPGNE) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SWX/PPGNE (SWX/PPGNE)

Price

Financial snapshot

Fair-value bridge

Latest news · SWX/PPGNE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SWX/PPGNE indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SWX/PPGNE

Frequently asked questions